Compound 1148
Identifiers
- Canonical SMILES:
CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(OC)c1
- IUPAC name:
4-[(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-3-methoxy-N-methylbenzamide
- InChi:
InChI=1S/C24H29N3O5/c1-16-15-26(24(30)18-8-6-5-7-9-18)12-13-27(16)23(29)17(2)32-20-11-10-19(22(28)25-3)14-21(20)31-4/h5-11,14,16-17H,12-13,15H2,1-4H3,(H,25,28)/t16-,17-/m1/s1
- InChiKey:
OQRSXFNMNAQFEB-IAGOWNOFSA-N
External links
![]() 45485396 |
![]() CHEMBL571586 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.77 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 439.21 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 1.76 | |||
TPSA | 88.18 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7000 | Itopride | DB04924 | |
0.6818 | Troxipide | DB13419 | |
0.6731 | Trimethobenzamide | DB00662 | |
0.6724 | Fipexide | DB13790 | |
0.6080 | Tiropramide | DB13091 | |
0.5979 | Etamivan | DB08989 | |
0.5680 | Flecainide | DB01195 | |
0.5472 | Bavisant | DB12299 | |
0.5328 | N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | DB07279 | |
0.5324 | Fallypride | DB15167 | |
0.5278 | Aniracetam | DB04599 | |
0.5217 | OTX-008 | DB13123 | |
0.5163 | CC-220 | DB12101 | |
0.5161 | Roxatidine acetate | DB08806 | |
0.5140 | Trimetazidine | DB09069 |